Epidermal pathogenesis of inflammatory dermatoses

American Journal of Contact Dermatitis

Volumn 10, Issue 3, 1999, Pages 119-126

  Elias, Peter M ^a   Wood, LaDonna C ^a   Feingold, Kenneth R ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; NERVE GROWTH FACTOR; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA;

ATOPIC DERMATITIS; COMPARTMENT MODEL; CYTOKINE RELEASE; HOMEOSTASIS; INFLAMMATION; PATHOGENESIS; PRIORITY JOURNAL; PSORIASIS; REVIEW; SKIN DISEASE; STRATUM CORNEUM;

EID: 0032859618     PISSN: 1046199X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1046-199X(99)90054-4     Document Type: Review

References (30)

1. Elias PM, Menon GK: Structural and lipid biochemical correlates of the epidermal permeability barrier. Adv Lipid Res 24:1-26, 1991
2. Holleran WM, Takagi Y, Feingold KR, et al: Processing of epidermal glucosylceramides is required for optimal mammalian permeability barrier function. J Clin Invest 91:1656-1664, 1993
3. 2 activity is required for permeability barrier homeostasis. J Invest Dermatol 106:57-63, 1996
4. Mauro T, Holleran WM, Grayson S, et al: Barrier recovery is impeded at neutral pH, independent of ionic effects: Implications for extracellular lipid processing. Arch Dermatol Res 290:215-222, 1998
5. Elias PM, Holleran WM, Menon GK, et al: Normal mechanisms and pathophysiology of epidermal permeability barrier homeostasis. Curr Opin Dermatol 231-237, 1993
6. Elias PM: Stratum corneum architecture, metabolic activity, and interactivity with subjacent cell layers. Exp Dermatol 5:191-201, 1996
7. Menon GK, Feingold KR, Elias PM. The lamellar body secretory response to barrier disruption. J Invest Dermatol 98:279-289, 1992
8. Holleran WM, Takagi Y, Menon GK, et al: Permeability barrier requirements regulate epidermal β-glucocerebrosidase. J Lipid Res 35:905-912, 1994
9. Harris IR, Farrell AM, Holleran WM, et al: Parallel regulation of sterol regulatory element binding protein-2 and the enzymes of cholesterol and fatty acid synthesis but not ceramide synthesis in cultured human keratinocytes and murine epidermis. J Lipid Res 39:412-422, 1998
10. Proksch E, Feingold KR, Mao-Quiang M, et al: Barrier function regulates epidermal DNA-synthesis. J Clin Invest 87:1668-1673, 1991
11. Feingold KR, Brown BE, Lear SR, et al: Effect of essential fatty acid deficiency on cutaneous sterol synthesis. J Invest Dermatol 87:588-591, 1986
12. Ghadially R, Brown BE, Sequeira-Martin SM, et al: The aged epidermal permeability barrier: structural, functional, and lipid biochemical abnormalities in humans and a senescent murine model. J Clin Invest 95:2281-2290, 1995
13. Reed JT, Ghadially R, Elias PM: Skin type, but neither race nor gender, influence epidermal permeability barrier function. Arch Dermatol 131:1134-1138, 1995
14. Denda M, Sato J, Masuda Y, et al: Exposure to a dry environment enhances epidermal permeability barrier function. J Invest Dermatol 111:858-863, 1998
15. Denda M, Tsuchiya T, Hirao T, et al: Psychological stress alters cutaneous permeability barrier homeostasis: Corticosteroid mediation of psychological stress-induced barrier homeostasis. (Submitted for publication)
16. Lee SH, Elias PM, Proksch E, et al: Calcium and potassium are important regulators of barrier homeostasis in murine epidermis. J Clin Invest 89:530-538, 1992
17. Menon GK, Elias PM, Lee SH, et al: Localization of calcium in murine epidermis following disruption and repair of the permeability barrier. Cell Tiss Res 270:503-512, 1992
18. Menon GK, Price LF, Bommannan B, et al: Selective obliteration of the epidermal calcium gradient leads to enhanced lamellar body secretion. J Invest Dermatol 102:789-795, 1994
19. Wood LC, Jackson SM, Elias PM, et al: Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice. J Clin Invest 90:482-487, 1992
20. Tsai J-C, Feingold KR, Crumrine D, et al: Permeability barrier disruption alters the localization and expression of TNF-alpha protein in the epidermis. Arch Derm Res 286:242-248, 1994
21. Wood LC, Feingold KR, Sequeira-Martin SM, et al: Barrier function coordinately regulates epidermal IL-1 and IL-1ra mRNA levels. Exp Dermatol 3:56-60, 1994
22. Liou A, Elias PM, Grunfeld C, et al: Amphiregulin and nerve growth factor expression are regulated by barrier status in murine epidermis. J Invest Dermatol 108:73-77, 1997
23. Denda M, Wood LC, Emami S, et al: The epidermal hyperplasia associated with repeated barrier disruption by acetone treatment or tape stripping cannot be attributed to increased water loss. Arch Dermatol Res 288:230-238, 1996
24. Wood LC, Elias PM, Sequeira-Martin SM, et al: Occlusion lowers cytokine mRNA levels in EFAD and normal mouse epidermis, but not after acute barrier disruption. J Invest Dermatol 103:834-838, 1994
25. Wood LC, Elias PM, Calhoun C, et al: Barrier disruption stimulates interleukin-1 alpha expression and release from a preformed pool in murine epidermis. J Invest Dermatol 106:397-403, 1996
26. Wood LC, Stalder AK, Liou A, et al: Barrier disruption increases gene expression of cytokines and the 55Kd TNF receptor in murine skin. Exp Dermatol 6:98-104, 1997
27. Stoschek et al: J Invest Dermatol 99:645, 1992
28. Mao-Qiang M, Wood L, Elias PM, et al: Cutaneous barrier repair and pathophysiology following barrier disruption in IL-1 and TNF Type I receptor deficient mice. Exp Dermatol 6:98-104, 1997
29. Elias PM, Ansel JC, Woods LC, et al: Signalling networks in barrier homeostasis: The mystery widens. Arch Dermatol 132:1505-1506, 1996
30. Elias PM, Wood LC, Feingold KR: Relationship of the epidermal permeability barrier to irritant contact dermatitis, in Beltrani V (ed): Immunology and Allergy Clinics of North America Vol. 17 (Contact Dermatitis: Irritant and Allergic). Philadelphia, PA, W.B. Saunders, 1997, pp 417-430